CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-09 | Schaffer Shane J. Chief Executive Officer | Shares withheld for taxes | −2,959 | 4,076 | ||
| 2026-03-09 | Patel Nilay Dahyabhai EVP, CLO and CCO | Grant or award | +5,475 | 5,475 | ||
| 2026-03-09 | Patel Nilay Dahyabhai EVP, CLO and CCO | Shares withheld for taxes | −2,086 | 3,389 | ||
| 2026-03-09 | Callahan Jennifer L. EVP and CFO | Grant or award | +15,329 | 20,388 | ||
| 2026-03-09 | Callahan Jennifer L. EVP and CFO | Shares withheld for taxes | −6,427 | 13,961 | ||
| 2026-03-09 | Brams Matthew EVP and Chief Medical Officer | Grant or award | +4,526 | 9,182 | ||
| 2026-03-09 | Brams Matthew EVP and Chief Medical Officer | Shares withheld for taxes | −1,025 | 8,157 | ||
| 2026-02-13 | Hargroves Thomas Jeffrey Director | Purchase | +97,276 | $5.04 | $490K | 97,468 |
| 2026-02-13 | Hargroves Thomas Jeffrey Director | Purchase · Warrant to Purchase Common Stock | +77,821 | $0.10 | $8K | 77,821 |
| 2026-02-06 | Werth Peter J. Director | Purchase | +19,455 | $5.04 | $98K | 117,449 |
| 2026-02-06 | Werth Peter J. Director | Purchase · Warrant to Purchase Common Stock | +15,564 | $0.10 | $2K | 15,564 |
| 2026-02-06 | Callahan Jennifer L. SVP and CFO | Purchase | +4,864 | $5.04 | $25K | 5,059 |
| 2026-02-06 | Callahan Jennifer L. SVP and CFO | Purchase · Warrant to Purchase Common Stock | +3,891 | $0.10 | $389 | 3,891 |
| 2026-02-06 | Schaffer Shane J. Chief Executive Officer | Purchase | +6,809 | $5.04 | $34K | 10,175 |
| 2026-02-06 | Schaffer Shane J. Chief Executive Officer | Purchase · Warrant to Purchase Common Stock | +5,447 | $0.10 | $545 | 5,447 |
| 2026-02-06 | Brams Matthew EVP and Chief Medical Officer | Purchase | +1,946 | $5.04 | $10K | 4,656 |
| 2026-02-06 | Brams Matthew EVP and Chief Medical Officer | Purchase · Warrant to Purchase Common Stock | +1,556 | $0.10 | $156 | 1,556 |
| 2025-12-31 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +6,625 | 6,625 | ||
| 2025-11-03 | Downey Bryan Wade Chief Commercial Officer | Grant or award · Stock Option (right to Buy) | +30,000 | 30,000 | ||
| 2025-09-30 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +7,334 | 7,334 |
Page 2 of 11 · 202 trades